Dublin · Seed–Late Stage · 13 people tracked
Also known as SEROBA LIFE SCIENCES LIMITED PARTNERSHIP
Find your way into Seroba Life Sciences
2,018 people in our graph share verified history with the Seroba Life Sciences team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
Founder mafia
2 people who came through Seroba Life Sciences went on to found or lead other companies.
What they invest in
from 25 of 35 portfolio companiesHealthtech ×23Medical Devices ×18Biotech ×16Deep Tech ×6Hardware ×4AI & Machine Learning ×3Digital Health ×3Consumer ×1
HQs:United States×7Ireland×5Germany×2Denmark×1France×1Italy×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×32 founders×43 founders×24+ founders×2
Where their founders studiedfrom 12 founders with education data
University of Galway ×2University of Groningen ×2
What their founders studiedfrom 10 founders with field-of-study data
Chemistry ×2Engineering ×2Life Sciences ×2
Where their founders worked beforefrom 13 founders with career history
BioInnovate Ireland ×2
Investments · 35 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 42022 · 22021 · 12020 · 12019 · 22017 · 32016 · 12014 · 22011 · 119 dated
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsJohnson & Johnson Innovation – JJDCLaunch Capital
Palliare develops medical devices for minimally invasive gastrointestinal procedures, including laparoscopy and endoscopy solutions.
HardwareHealthtechMedical DevicesOceanside, IE
John O'Dea(CEO)in
Co-investorsWestern Development Commission
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalV-Bio VenturesVertis SGRVI PartnersClaris Ventures+1 more
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCAgent Capital+2 more
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesThuja CapitalBGV
Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.
FemTechHealthtechMedical Devices
Co-investorsAndera PartnersEarlybird Venture Capital
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioMedPartnersForbionJeito CapitalBioGeneration VenturesPictet Group
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Kurma PartnersV-Bio VenturesBpifranceInvusNovo Holdings+1 more
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalHadean VenturesBGVBioGeneration VenturesForbionGimv+2 more
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsAct Venture CapitalACT Venture CapitalClaret Capital PartnersMolten Ventures
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony I Nunez(Executive Officer, Director)inAnthony A. Nunez(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)
Co-investorsBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSV Health InvestorsLSP (Life Sciences Partners)
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesVenture OntarioYsios CapitalAdams Street Partners+2 more
BiotechSunnyvale, US
Richard Ellson(Executive Officer, Director)Tammy Cameron(Executive Officer)Mark Fischer-Colbrie(Executive Officer, Director)
BoardJoseph Smith(Director)Sandra Panem(Director)Joe Keegan(Director)
Co-investorsGE VenturesJP Morgan Chase
Seroba Ventures is an investment firm focused on bringing breakthrough healthcare solutions to market and addressing unmet patient needs in the global healthcare environment.
BiotechHealthtechMedical Devices
Jeanne Bolger(Venture Partner)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSV Health InvestorsEnterprise IrelandEQT Life Sciences
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSunstone CapitalYsios CapitalForbion
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Co-investorsAccelComma Capital
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
Co-investorsEpidarex Capital
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.
BiotechHealthtechMedical DevicesDublin, IE
Sharon Cunningham(CEO & Co-Founder)inOrlaith Ryan(CTO & Co-Founder)in
Co-investorsKurma PartnersEnterprise Ireland
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+1 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresEQT Life SciencesEurazeoIdinvest Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Agi TherapeuticsApica CardiovascularCovagen AGHeart MetabolicsINNOVO by Atlantic TherapeuticsMedLumicsNovateNovate MedicalPQ BypassShorla PharmaXention
Exits · 2
2 acquisitionsCovagen AGacq. by Johnson & JohnsonPrexton Therapeuticsacq. by Lundbeck
Portfolio news
latest coverage across their companies
Alveus Therapeutics · fiercebiotech.com · Aug 12, 2026
Quanta · finance.yahoo.com · Aug 11, 2026
Precision Biotics · market.us · Aug 4, 2026
Coave Therapeutics · biopharminternational.com · May 26, 2026
Storm Therapeutics · bioxconomy.com · Apr 17, 2026
Loci · finance.yahoo.com · Feb 25, 2026
Deciphex · founderstoday.news · Oct 3, 2025
Azafaros · siliconcanals.com · May 14, 2025
Frequently asked questions
- How many investments has Seroba Life Sciences made?
- Seroba Life Sciences has 35 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does Seroba Life Sciences invest at?
- Seroba Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Seroba Life Sciences's typical check size?
- Seroba Life Sciences typically writes checks of $540K – $7.6M.
- What sectors does Seroba Life Sciences focus on?
- Seroba Life Sciences focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Seroba Life Sciences located?
- Seroba Life Sciences is headquartered in Dublin, IE.
- Who does Seroba Life Sciences co-invest with?
- Seroba Life Sciences most often shares deals with Andera Partners, Kurma Partners, Ysios Capital, among 47 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBruno MONTANARI, Partner, SEROBA LIFE SCIENCES
IPEM · Bruno Montanari
Co-investors · 12
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.
Molten Ventures is a European venture capital firm that backs technology founders from Series A onward, providing capital along with expertise and networks to help companies scale globally.
Atlantic Bridge is a growth equity firm investing in deep technology companies across Europe, the UK and the US, using a cross-border value-add strategy and a global platform to help portfolio companies scale internationally.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Borski Fund is a venture capital fund that invests in gender-diverse, female-(co)-led companies in the Netherlands and UK, aiming to improve access to financial and social capital for founders.
Claris Ventures is an early-stage investor that makes equity investments in biopharma companies with strong scientific evidence and a clear vision.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Karista is a French venture capital firm that invests in tech and early-stage companies, frequently leading funding rounds and supporting founders through strategic guidance and board involvement.
Firms observed investing alongside Seroba Life Sciences, from public investor directories. Shared companies are the overlap with Seroba Life Sciences's recorded portfolio.
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
Clal Biotechnology Industries (TASE: CBI) is an Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange, focused on identifying and developing ventures that create proprietary solutions for unmet medical needs.